Immune signature as predictive marker for response to checkpoint inhibitor immunotherapy and overall survival in melanoma

BACKGROUND: Malignant melanoma is an immunogenic skin cancer with an increasing global incidence. Advanced stages of melanoma have poor prognoses. Currently, there are no reliable parameters to predict a patient's response to immune checkpoint inhibitor (ICI) therapy. METHODS: This study highli...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer Med
Main Authors: Krebs, Franziska K., Trzeciak, Emily R., Zimmer, Sophia, Özistanbullu, Deniz, Mitzel‐Rink, Heidrun, Meissner, Markus, Grabbe, Stephan, Loquai, Carmen, Tuettenberg, Andrea
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2021
Fag:
Clinical Cancer Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7940230/
https://ncbi.nlm.nih.gov/pubmed/33449393
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3710
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker